Meir Medical Center Rheumatologic Biobank

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorMeir Medical Center

About this trial

Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

above 18 years of age

willing to sign informed consent

have a rheumatoid condition

Disqualifiers

None

Trial population

patients of our rheumatological clinic which have a rheumatolid condition and are willing to sign an informed consent.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

500 Participants
are grouped into 4 trial groups
Group A: RA patients
Group B: Systemic sclerosis patients
Group C: IgG4 RD patients
Group D: Lupus patients

Trial outcomes

Primary outcomes

1

collecting samples

IgG4-related disease patients

Time frame
20 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.